FDA to Review 7 Peptides for Compounding List in July 2026: BPC-157, Semax, Epitalon, and More
The FDA will convene its Pharmacy Compounding Advisory Committee on July 23-24, 2026 to review BPC-157, KPV, TB-500, MOTS-C, DSIP, Semax, and Epitalon for inclusion on the 503A Bulks List.
Read More